Highly bioavailable oral delayed release dosage forms of Odesmethylvenlafaxine succinate

Details for Australian Patent Application No. 2006270315 (hide)

Owner Wyeth

Inventors Diorio, Christopher Richard; Fawzi, Mahdi B.; Shah, Syed M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006270315

PCT Pub. Number WO2007/011619

Priority 60/699,623 15.07.05 US

Filing date 13 July 2006

Wipo publication date 25 January 2007

International Classifications

A61K 9/32 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/011619 Priority application(s): WO2007/011619

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006270317-Method and apparatus for reinvesting winnings

2006270313-Method and system for automated responsible gaming controls